Skip to main content

Advertisement

Log in

Antioxidants vitamin C and vitamin E for the prevention and treatment of cancer

  • Original Articles
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

Abstract

OBJECTIVE: To evaluate the evidence of the supplements vitamin C and vitamin E for treatment and prevention of cancer.

METHODS: Systematic review of trials and meta-analysis.

DATA SOURCES AND MAIN RESULTS: Thirty-eight studies showed scant evidence that vitamin C or vitamin E beneficially affects survival. In the ATBC Cancer Prevention Study Group, no statistically significant effect of treatment was seen for any cancer individually, and our pooled relative risk (regardless of tumor type) for α-tocopherol alone was 0.91 (95% confidence interval [CI]: 0.74, 1.12). All cause mortality was not significant. In the Linxian General Population Trial, the relative risks for cancer death for vitamin C (combined with molybdenum) was 1.06 (95% CI: 0.92, 1.21) and for vitamin E (combined with β-carotene and selenium) was 0.87 (95% CI: 0.76, 1.00). We identified only 3 studies that reported statistically significant beneficial results: vitamin C (in combination with BCG) was found to be beneficial in a single trial of bladder cancer and vitamin E (in combination with ω-3 fatty acid) increased survival in patients with advanced cancer. In the ATBC trial, in analyses of 6 individual cancers, the prevention of prostate cancer in subjects treated with α-tocopherol was statistically significant (RR=0.64, 95% CI: 0.44, 0.94).

CONCLUSIONS: The systematic review of the literature does not support the hypothesis that the use of supplements of vitamin C or vitamin E in the doses tested helps prevent and/or treat cancer in the populations tested. There were isolated findings of benefit, which require confirmation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. IOM (Institute of Medicine). Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: National Academy Press; 2000.

    Google Scholar 

  2. Young VR, Newberne PM. Vitamins and cancer prevention: issues and dilemmas. Cancer. 1981;47:1226–40.

    Article  PubMed  CAS  Google Scholar 

  3. Block G, Levine M, Vitamin C. A new look. Ann Intern Med. 1991;114:909–10.

    PubMed  CAS  Google Scholar 

  4. Blumberg J, Heber D. Multivitamins & Public Health: Exploring the Evidence. Summary Statement From Multivitamins & Public Health: Exploring the Evidence; October 1, 2003. Washington, DC: BioScience Communications; 2004.

    Google Scholar 

  5. Shekelle P, Coulter I, Hardy M, et al. Effect of Supplemental Antioxidants Vitamin C, Vitamin E, and Coenzyme Q10 for the Prevention and Treatment of Cardiovascular Disease. Evidence Report/Technology Assessment No. 83 (Prepared by Southern California-RAND Evidence-Based Practice Center, Under Contract No. 290-97-0001). AHRQ Publication No. 03-E043. Rockville, MD: Agency for Healthcare Research and Quality; 2003. Available at: http://www.ahrq.gov/downloads/pub/evidence/pdf/antioxcan/antioxcan.pdf.

    Google Scholar 

  6. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408–12.

    Article  PubMed  CAS  Google Scholar 

  7. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1–12.

    Article  PubMed  CAS  Google Scholar 

  8. Moher D, Pham B, Jones A, et al. Does the poor quality of reports of randomized trials exaggerate estimates of intervention effectiveness reported in meta-analyses. Lancet. 1998;352:609–13.

    Article  PubMed  CAS  Google Scholar 

  9. Microsoft Corporation Microsoft Excel for Windows 2000. Redmond, WA: Microsoft Corporation; 2000.

    Google Scholar 

  10. Stata Corporation Stata Statistical Software: Release 6.0 Ver. 6.0. College Station, TX: Stata Corporation; 1999.

    Google Scholar 

  11. Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. The effects of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994;330:1029–35.

    Article  Google Scholar 

  12. Li J, Taylor P, Li B, et al. Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia. J Natl Cancer Inst. 1993;85:1492–8.

    Article  PubMed  CAS  Google Scholar 

  13. Blot W, Li JY, Taylor PR, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst. 1993;85:1483–92.

    Article  PubMed  CAS  Google Scholar 

  14. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.

    Article  PubMed  CAS  Google Scholar 

  15. Hedges LV, Olkin I. Statistical Methods for Meta-Analysis. San Diego, CA: Academic Press Inc.; 1985.

    Google Scholar 

  16. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–101.

    Article  PubMed  CAS  Google Scholar 

  17. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.

    PubMed  CAS  Google Scholar 

  18. Li B, Taylor PR, Li JY, et al. Linxian nutrition intervention trials: design, methods, participant characteristics, and compliance. Ann Epidemiol. 1993;3:577–85.

    Article  PubMed  CAS  Google Scholar 

  19. Taylor PR, Li B, Dawsey SM, et al. Prevention of esophageal cancer: the nutrition intervention trials in Linxian, China. Linxian Nutrition Intervention Trials Study Group. Cancer Res. 1994;54:2029s-31s.

    PubMed  CAS  Google Scholar 

  20. Albanes D, Virtamo J, Rautalahti M, et al. Pilot study: the US-Finland lung cancer prevention trial. J Nutr Growth Cancer. 1986;3:207–14.

    Google Scholar 

  21. Albanes D, Heinonen OP, Taylor PR, et al. Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst. 1996;88:1560–70.

    Article  PubMed  CAS  Google Scholar 

  22. Albanes D, Malila N, Taylor PR, et al. Effects of supplemental alpha-tocopherol and beta-carotene on colorectal cancer: results from a controlled trial (Finland). Cancer Causes Control. 2000;11:197–205.

    Article  PubMed  CAS  Google Scholar 

  23. Blot W. Preventing cancer by disrupting progression of precancerous lesions. J Natl Cancer Inst. 2000;92:1868–9.

    Article  PubMed  CAS  Google Scholar 

  24. Creagan ET, Moertel CG, O’Fallon JR, et al. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N Engl J Med. 1979;301:687–90.

    PubMed  CAS  Google Scholar 

  25. Creagan ET, Moertel CG, Schutt AJ, Oconnell MJ. Vitamin-c (ascorbic-acid) therapy of pre-terminal cancer-patients. 1979;20:355–6.

  26. Gogos CA, Ginopoulos P, Salsa B, Apostolidou E, Zoumbos NC, Kalfarentzos F. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial. Cancer. 1998;82:395–402.

    Article  PubMed  CAS  Google Scholar 

  27. Heinonen OP, Albanes D, Virtamo J, et al. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst. 1998;90:414–5.

    Article  Google Scholar 

  28. Lamm D, Riggs DR, Shriver JS, vanGilder PF, Rach JF, DeHaven JI. Megadose vitamins in bladder cancer: a double-blind clinical trial. J Urol. 1994;151:21–6.

    PubMed  CAS  Google Scholar 

  29. Moertel CG, Fleming TR, Creagan ET, Rubin J, O’Connell MJ, Ames MM. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N Engl J Med. 1985;312:137–41.

    PubMed  CAS  Google Scholar 

  30. MRC/BHF Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:23–33.

    Article  Google Scholar 

  31. Ascorbic acid does not cure cancer. Nutr Rev. 1985;43:146–7.

  32. Poulter JM, White WF, Dickerson JW. Ascorbic acid supplementation and five year survival rates in women with early breast cancer. Acta Vitaminol Enzymol. 1984;6:175–82.

    PubMed  CAS  Google Scholar 

  33. Rautalahti MT, Virtamo JR, Taylor PR, et al. The effects of supplementation with alpha-tocopherol and beta-carotene on the incidence and mortality of carcinoma of the pancreas in a randomized, controlled trial. Cancer. 1999;86:37–42.

    Article  PubMed  CAS  Google Scholar 

  34. Virtamo J, Edwards BK, Virtanen M, et al. Effects of supplemental alpha-tocopherol and beta-carotene on urinary tract cancer: incidence and mortality in a controlled trial (Finland). Cancer Causes Control. 2000;11:933–9.

    Article  PubMed  CAS  Google Scholar 

  35. Dawsey SM, Wang GQ, Taylor PR, et al. Effects of vitamin/mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach: results from the Dysplasia Trial in Linxian, China. Cancer Epidemiol Biomarkers Prev. 1994;3:167–72.

    PubMed  CAS  Google Scholar 

  36. Varis K, Taylor PR, Sipponen P, et al. Gastric cancer and premalignant lesions in atrophic gastritis: a controlled trial on the effect of supplementation with alpha-tocopherol and beta-carotene. The Helsinki Gastritis Study Group. Scand J Gastroenterol. 1998;33:294–300.

    Article  PubMed  CAS  Google Scholar 

  37. Greenberg ER, Baron JA, Tosteson TD, et al. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. N Engl J Med. 1994;331:141–7.

    Article  PubMed  CAS  Google Scholar 

  38. McKeown-Eyssen G, Holloway C, Jazmaji V, Bright-See E, Dion P, Bruce WR. A randomized trial of vitamins C and E in the prevention of recurrence of colorectal polyps. Cancer Res. 1988;48:4701–5.

    PubMed  CAS  Google Scholar 

  39. Hofstad B, Almendingen K, Vatn M, et al. Growth and recurrence of colorectal polyps: a double-blind, three-year intervention with calcium and antioxidants. Digestion. 1998;59:148–56.

    Article  PubMed  CAS  Google Scholar 

  40. Roncucci L, Di Donato P, Carati L, et al. Antioxidant vitamins or lactulose for the prevention of the recurrence of colorectal adenomas. Colorectal Cancer Study Group of the University of Modena and the Health Care District 16. Dis Colon Rectum. 1993;36:227–34.

    Article  PubMed  CAS  Google Scholar 

  41. Roncucci L, Ponz de Leon M. Antioxidant vitamins or lactulose as chemopreventive agents for colorectal cancer. In: Waldron K, Johnson I, Fenwick G, eds. Food and Cancer Prevention: Chemical and Biological Aspects. Cambridge, UK: Royal Society of Cambridge; 1993:147–50.

    Google Scholar 

  42. Bussey HJ, DeCosse JJ, Deschner EE, et al. A randomized trial of ascorbic acid in polyposis coli. Cancer. 1982;50:1434–9.

    Article  PubMed  CAS  Google Scholar 

  43. Cahill RJ, O’Sullivan KR, Mathias PM, Beattie S, Hamilton H, O’Morain C. Effects of vitamin antioxidant supplementation on cell kinetics of patients with adenomatous polyps. Gut. 1993;34:963–7.

    Article  PubMed  CAS  Google Scholar 

  44. Malila N, Virtamo J, Virtanen M, Albanes D, Tangrea JA, Huttunen JK. The effect of alpha-tocopherol and beta-carotene supplementation on colorectal adenomas in middle-aged male smokers. Cancer Epidemiol Biomarkers Prev. 1999;8:489–93.

    PubMed  CAS  Google Scholar 

  45. Lonn E, Bosch J, Yusuf S, et al. HOPE and HOPE-TOO Trial Investigators. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA. 2005;293:1338–47.

    Article  PubMed  Google Scholar 

  46. Lee IM, Cook NR, Gaziano JM, et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: the women’s health study: a randomized controlled trial. JAMA. 2005;294:56–65.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ian D. Coulter PhD.

Additional information

None of the authors have any conflicts of interest to declare.

This research was conducted by the Southern California Evidence-Based Practice Center based at RAND, Santa Monica, CA under contract to the Agency for Healthcare Research and Quality (AHRQ) (Contract No. 290-97-0001). The research was requested and funded by the National Center for Complementary and Alternative Medicine (NCCAM), National Institutes of Health (NIH). The authors of this manuscript are responsible for its contents, including any clinical or treatment recommendations. The opinions expressed in this article are those of the authors and do not necessarily reflect the official position of AHRQ, or of NCCAM, NIH, or of the U.S. Department of Health and Human Services. We wish to acknowledge the work of Leigh Rohr, RAND Corporation, in the preparation of this manuscript.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Coulter, I.D., Hardy, M.L., Morton, S.C. et al. Antioxidants vitamin C and vitamin E for the prevention and treatment of cancer. J Gen Intern Med 21, 735–744 (2006). https://doi.org/10.1111/j.1525-1497.2006.00483.x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1111/j.1525-1497.2006.00483.x

Key words

Navigation